Researchers Begin Trial Comparing Two ACL Reconstruction Grafts
A new randomized clinical trial is comparing bone-patellar tendon-bone and quadriceps tendon grafts, focusing on postoperative anterior knee pain.
A clinical trial beginning in October 2026 is comparing two commonly used graft options for anterior cruciate ligament reconstruction, with particular attention to pain outcomes following surgery.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Anterior cruciate ligament injuries are common among athletes and physically active people and can cause instability, pain and difficulty returning to sports. When reconstruction is required, surgeons can use different types of grafts to replace the damaged ligament.
A newly registered randomized clinical trial is comparing bone-patellar tendon-bone grafts with quadriceps tendon grafts for ACL reconstruction. One of the main outcomes being evaluated is postoperative anterior knee pain.
This is clinically relevant because graft choice can influence rehabilitation, pain and functional recovery. Although both approaches are widely used, questions remain about which patients may experience better outcomes with particular graft choices.
The trial is expected to follow participants over an extended period, allowing researchers to compare outcomes rather than relying solely on immediate postoperative results.
The research could contribute to more individualized ACL reconstruction decisions, particularly when surgeons discuss the advantages and disadvantages of different graft options with patients.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
